Related Experiment Video
Updated: Jul 10, 2026
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Tumor-derived death receptor 6 modulates dendritic cell development
David C DeRosa1, Paul J Ryan, Angela Okragly
1Eli Lilly and Company, BioTherapeutic Discovery Research, Indianapolis, IN 46285, USA.
Cancer Immunology, Immunotherapy : CII
|October 27, 2007
Summary
Tumor cells can evade immune detection by shedding Death Receptor 6 (DR6), which impairs the development of crucial antigen-presenting dendritic cells (DCs). This shedding is mediated by matrix metalloproteinase-14 (MMP-14).
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Cancer immune evasion is a major challenge in oncology.
- Dendritic cells (DCs) are key players in initiating anti-tumor immune responses.
- Death Receptor 6 (DR6) is implicated in immune regulation and is overexpressed in some cancers.
Purpose of the Study:
- To investigate the role of DR6 in cancer immune evasion.
- To determine if DR6 negatively impacts anti-tumor immunity by affecting DC generation.
- To explore the mechanism of DR6 shedding and its consequences on DCs.
Main Methods:
- Studied DR6 expression and shedding in cancer cell lines.
- Investigated the effect of soluble DR6 on monocyte-derived DC differentiation and function.
- Utilized murine models and human cancer patients' data.
- Analyzed DC phenotype, cytokine production, and antigen presentation capacity.
Main Results:
- DR6 is cleaved from tumor cell surfaces by matrix metalloproteinase-14 (MMP-14).
- Soluble DR6 significantly inhibits the differentiation of monocytes into DCs (>50% cell death).
- DR6 alters immature DC phenotype and cytokine profiles, impacting antigen presentation, though maturation partially restores function.
Conclusions:
- MMP-14-mediated shedding of DR6 is a novel mechanism of tumor immune evasion.
- This process compromises the generation and function of antigen-presenting cells (APCs).
- Targeting the MMP-14/DR6 axis may represent a therapeutic strategy to enhance anti-tumor immunity.
Related Concept Videos
01:15Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...